Cargando…
Eosinophil-independent IL-5 levels are increased in critically ill COVID-19 patients who survive
Autores principales: | Ju, Xiaotian, Son, Kiho, Jamil, Rameen, Culgin, Sarah, Salter, Brittany, Miyasaki, Kate, Fard, Nahal Emami, Xiao, Maria, Patel, Zil, Zhang, Kayla, Cowbrough, Braeden, Kjarsgaard, Melanie, Radford, Katherine, Dvorkin-Gheva, Anna, Richards, Carl D., Cox, Gerard, Chagla, Zain, Smieja, Marek, Tunks, Marcel, Alhazzani, Waleed, Bowdish, Dawn M.E., Perri, Dan, Nair, Parameswaran K., Sehmi, Roma, Mukherjee, Manali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318811/ https://www.ncbi.nlm.nih.gov/pubmed/37403168 http://dx.doi.org/10.1186/s13223-023-00810-6 |
Ejemplares similares
-
Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms
por: Son, Kiho, et al.
Publicado: (2022) -
Regulatory ILC2—Role of IL-10 Producing ILC2 in Asthma
por: Emami Fard, Nahal, et al.
Publicado: (2023) -
Dysregulation of Vascular Endothelial Progenitor Cells Lung-Homing in Subjects with COPD
por: Salter, Brittany M., et al.
Publicado: (2016) -
Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
por: Mukherjee, Manali, et al.
Publicado: (2017) -
Anti-IL5 therapy for asthma and beyond
por: Mukherjee, Manali, et al.
Publicado: (2014)